bioecon Member area
Suppliers · Producer

NewLimit

NewLimit develops therapeutic medicines focused on epigenetic reprogramming to treat diseases of aging and restore youthful function in cells.

active United StatesUSA & Canada Founded 2021 checked 2026-10-16 research 2026-10

Profile

Industry
Healthy-Aging & Longevity Economy
Topics
Role
Producer — “…NewLimit develops therapeutic medicines focused on epigenetic reprogramming to treat diseases of aging and restore youthful function in cells.…”

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

Status

    Network: owners, partners, peers

    Identity & contacts

    Contacts, people and legal identity are available to members.

    Sign in as a member